Synthetic options for conversion of indeno[2,1‐c]fluorene‐5,8‐diones into larger polyaromatic compounds with extended π‐conjugated systems were explored. The crucial two‐fold transformation of the five‐membered ketone moieties of indeno[2,1‐c]fluorene‐5,8‐diones was based either on a one‐carbon homologation or on a ring‐expansion reaction which eventually enabled syntheses of compounds possessing substituted tribenzo[a,e,l]indeno[1,2,3‐hi]acephenanthrylenes and [5]helicenes scaffolds. The former was prepared by using a reaction sequence based on Ramirez olefination, intramolecular Heck reaction, and intermolecular Suzuki‐Miyaura cross‐coupling, whereas the latter utilized a sequence comprising Büchner−Curtius−Schlotterbeck reaction and intermolecular Suzuki‐Miyaura cross‐coupling. Scholl reaction of selected [5]helicenes yielded planarized polyaromatic compounds with the tribenzo[a,e,l]indeno[1,2,3‐hi]acephenanthrylene scaffold. Where possible, structures of products were confirmed by X‐ray diffraction analyses. Photophysical properties were determined as well.

Four diastereomers of 16-azidomethyl substituted 3-O-benzyl estradiol (1–4) and their two estrone analogs (16AABE and 16BABE) were tested for their antiproliferative properties against human gynecological cancer cell lines. The estrones were selected for additional experiments based on their outstanding cell growth-inhibiting activities. Both compounds increased hypodiploid populations of breast cancer cells, and 16AABE elicited cell cycle disturbance as evidenced by flow cytometry. The two analogs substantially increased the rate of tubulin polymerization in vitro. 16AABE and 16BABE inhibited breast cancer cells’ migration and invasive ability, as evidenced by wound healing and Boyden chamber assays. Since both estrone analogs exerted remarkable estrogenic activities, as documented by a luciferase reporter gene assay, they can be considered as promising drug candidates for hormone-independent malignancies.

Steroidal sulfamates inhibit cancer-related CA IX by binding its zinc active site. Estra-1,3,5(10)-triene and Δ5-steroids show strong, selective activity, highlighting their potential as targeted anticancer agents.